GSK (GSK) Stock Price & Analysis
GSK (GSK) rose 0.00% to USD 51.35 as of July 25, 2026 at 01:46 UTC, according to Nexqual real-time market data.
GSK last closed at USD 51.35; the session ranged USD 51–51.56 on volume of 5,863,112 shares. Market capitalization is —, with a 52-week range of USD 36.75–61.7 (NYQ). Source: Nexqual, July 25, 2026 at 01:46 UTC.
Key Statistics (as of July 25, 2026 at 01:46 UTC)
| Price | USD 51.35 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 51.35 |
| Open | USD 51.35 |
| Day Range | USD 51 – 51.56 |
| 52-Week Range | USD 36.75 – 61.7 |
| Volume | 5,863,112 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (GSK)
Nexqual's technical model rates GSK "STRONG SELL" based on 0 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 01:46 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 48.19 (neutral) |
| vs SMA50 | Below (USD 51.49) |
| MACD | -0.26 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SNY | Sanofi | USD 43.35 | ▼ 1% |
| NVS | Novartis AG | USD 155.01 | ▲ 1.26% |
| AZN | AstraZeneca PLC | USD 169.26 | ▼ 0.28% |
| BMY | Bristol-Myers Squibb Company | USD 62.09 | ▲ 2.19% |
| MRK | Merck & Company, Inc. | USD 131.07 | ▲ 2.82% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:46 UTC. This page is informational and not investment advice.